JUN and melanoma: Together, these results suggest that the reduction of intratumor production of HIF-1α and of pAP-1 c-Jun by combined liposomal therapy with LCL-SIM + LCL-DOX significantly weakened the invasive and metastatic ability of B16.F10 melanoma cells, via strong inhibition of MMPs activity.